Pioneering Pharma Solutions
BagRx Pharmaceutical delivers end-to-end pharma solutions, from high-quality formulations to seamless distribution. We specialize in third-party manufacturing, pharma franchise opportunities, and contract manufacturing of tablets, capsules, syrups, and injectables.
With WHO-GMP certified facilities, rigorous quality control, and a pan-India network, we empower partners with innovative, affordable, and compliant healthcare products. Our expertise spans anti-infectives, nutraceuticals, and chronic therapies, ensuring trusted, scalable, and profitable partnerships for distributors, hospitals, and pharmacies.


Femina Range
Femina Range offers specialized gynecological formulations, providing safe, effective solutions for women's health at every life stage with trusted quality. Our scientifically-backed, gynecologist-approved products address reproductive health, hormonal balance, and comprehensive feminine care needs.

Third Party Pharma Manufacturing
Third Party Pharma Manufacturing offers cost-effective, compliance-driven production solutions, enabling brands to expand their portfolio with high-quality tablets, capsules, and injectables without capital investment in infrastructure or regulatory approvals.
WHO-GMP Certified Quality Assurance
Our WHO-GMP certification validates strict quality control at every production stage, delivering trusted medicines that meet international safety benchmarks.
FEMINA: The Gynecological Division
In an era where women's wellness takes center stage, Bagrx Pharmaceutical proudly unveils its visionary Femina Division – a dedicated powerhouse for gynecological innovation. Addressing the soaring demand for premium women's healthcare solutions, Femina presents an exclusive Gynae PCD Franchise Opportunity, empowering entrepreneurs to build rewarding ventures in this vital sector.
Femina by Bagrx boasts an elite portfolio of 10+ breakthrough formulations, establishing us as pioneers in gynecological therapeutics. The Femina Division invites dynamic partners to capitalize on this golden market opportunity.
